NCI Cancer Bulletin
A Trusted Source for Cancer Research News
200th Issue
December 16, 2008 • Volume 5 / Number 25 E-Mail This Document  |  Download PDF  |  Bulletin Archive/Search  |  Subscribe

Bulletin Home

Featured Article
Trials Suggest Potential Expanded Use for HER2-Targeted Agents

Cancer Research Highlights
Surgery Alone May Be Best for Early Uterine Cancer

Studies Assess the Economic Impact of Cancer Deaths

Meta-analysis Highlights Progress in Treating Advanced Breast Cancer

Rituximab Improves Outcomes for CLL Patients

Director's Update
Cancer Research in a New Light

Two Prevention Trials Show Antioxidants Do Not Cut Cancer Risk

Special Report
Researchers Uncover Gene for Melanoma of the Eye Update
Insurance Coverage Laws for Patients in Clinical Trials

Profiles in Cancer Research
Dr. David Sidransky

Tweaking and Testing Cancer Stem Cell Models

Featured Clinical Trial
Targeted Treatment for Advanced Solid Tumors

Winn Named DCCPS Deputy Director

Cancer Snapshots Collection Updated

New Spanish Language Education Resources Available

Community Update
Cancer Communications Initiative Expands into the Real World

Bulletin Archive

About the Bulletin

Page Options
Print This Page
Print This Document
View Entire Document
E-Mail This Document
View/Print PDF
Two Prevention Trials Show Antioxidants Do Not Cut Cancer Risk

Data are now available from more than 35,000 men aged 50 and older who participated in the NCI-funded Selenium and Vitamin E Cancer Prevention Trial (SELECT), indicating that selenium and vitamin E supplements did not prevent prostate cancer, when taken either alone or together. The data also show small, statistically insignificant increases in prostate cancer cases among men who took only vitamin E and also in adult-onset diabetes cases among men taking only selenium.

Another trial, the Physicians' Health Study II, followed more than 14,600 male physicians aged 50 years and older who took vitamin E, vitamin C, a combination of both, or placebos over a 10-year period. The rates of prostate, colorectal, lung, and other cancers were similar among all study groups.

Results from both trials were published online December 9 in the Journal of the American Medical Association. "Physicians should not recommend selenium or vitamin E - or any other antioxidant supplements - to their patients for preventing prostate cancer," wrote Dr. Peter Gann of the University of Illinois at Chicago in an accompanying editorial.

< Previous Section  |  Next Section >

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health